Assignee
KHONDRION IP B V
NL·8 granted patents·1 pending application·16 citations·filing 2013–2024
Top patents by PatentIndex Score
9 records- 0187US11357767B2Compounds for use in treating depression and migraineKHONDRION IP B V·Filed 2018·Granted Jun 14, 2022·4 cites·16 claims
- 0282US10815211B2Compounds for treating mitochondrial diseaseKHONDRION IP B V·Filed 2016·Granted Oct 27, 2020·3 cites·7 claims
- 0381US11672787B2Compounds as mPGES-1 inhibitorsKHONDRION IP B V·Filed 2018·Granted Jun 13, 2023·2 cites·17 claims
- 0478US11285130B2Treatment of mitochondrial diseasesKHONDRION IP B V·Filed 2017·Granted Mar 29, 2022·1 cites·21 claims
- 0578US9388156B2Chromanyl derivatives for treating mitochondrial diseaseKHONDRION IP B V·Filed 2013·Granted Jul 12, 2016·6 cites·17 claims
- 0676US2024390321A1Treatment of mitochondrial diseasesKHONDRION IP B V·Filed 2024·Application pending·0 cites
- 0769US12226394B2Treatment of mitochondrial diseasesKHONDRION IP B V·Filed 2022·Granted Feb 18, 2025·0 cites·20 claims
- 0866US12208090B2Compounds for use in treating depression and migraineKHONDRION IP B V·Filed 2022·Granted Jan 28, 2025·0 cites·10 claims
- 0953US11530190B2Compounds for treating mitochondrial diseaseKHONDRION IP B V·Filed 2020·Granted Dec 20, 2022·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when KHONDRION IP B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →